This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
CNS drug developer Newron grosses CHF118mm in IPO on SWX
18 Dec 2006
Italian firm Newron Pharmaceuticals SPA (CNS diseases) has raised CHF118mm ($99mm) through its initial public offering on the SWX Swiss Exchange. It sold 2.15mm shares for CHF55 each, landing in the upper end of its planned CHF45-60 price range.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?